Viewing Study NCT05229094


Ignite Creation Date: 2025-12-25 @ 1:32 AM
Ignite Modification Date: 2025-12-25 @ 11:45 PM
Study NCT ID: NCT05229094
Status: COMPLETED
Last Update Posted: 2022-07-05
First Post: 2021-12-24
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: EVA Nexus Vitrectomy Device Field Observation Study
Sponsor: Universitaire Ziekenhuizen KU Leuven
Organization:

Study Overview

Official Title: EVA Nexus Field Observation Study. A Monocentric, Academic Field Observation Study of a Prototype of a New CE-labeled Vitrectomy Device Developed by DORC BV (The Netherlands).
Status: COMPLETED
Status Verified Date: 2022-06
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: determine the safety and effectiveness of the device.
Detailed Description: To perform a field observation study using the newly developed EVA Nexus vitrectomy device.

Patients that are scheduled for intra-ocular surgery regardless of the indication:

* Vitrectomy surgery
* Cataract surgery
* Vitrectomy combined with cataract surgery

Study Oversight

Has Oversight DMC: False
Is a FDA Regulated Drug?: False
Is a FDA Regulated Device?: False
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: